Context The incidence of bladder cancer is three to four times greater in men than in women.
However, women are diagnosed with more advanced disease at presentation and have less …

Introduction While patient gender is an important factor in the clinical decision-making for the
management of bladder cancer, there are minimal evidence-based recommendations to …

Men are at a higher risk of developing bladder cancer, but women present with more
advanced disease and have more unfavourable outcomes. Although epidemiologic and …

Background: A higher incidence of bladder cancer has been reported in men compared with
women. Clinical gender differences have been observed but are less well described …

Bladder cancer is the fourth most commonly diagnosed cancer in men and the eighth most
common in women in the United States. While clinicians who diagnose and treat the disease …

While men are at a considerable higher risk of developing urothelial carcinoma of the
bladder (UCB), women present with more advanced disease stages and seem to …

While patient age and gender are important factors in the clinical decision‐making for
treating urothelial carcinoma of the bladder (UCB), there are no evidence‐based …

Background While urinary bladder cancer is consistently more common in men worldwide,
women have poorer prognosis. The aim of this study was to outline sex differences in …

It has long been known that bladder cancer (BC) incidence is approximately four-fold higher
in men than in women in the United States, and a similar disparity also exists in other …

A gender discrepancy exists in the incidence of both urothelial and kidney carcinomas, with
more men presenting with these cancers than women. Men have a threefold greater risk of …